| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 08.05.2007 (6404
dage). |
Ingen historik.
| Branche | | Ventureselskaber og kapitalfonde (643040). |
| Sidst opdateret den 15.03.2019 og
angivet som gældende fra 11.03.2019 (2079
dage). |
| Historik | Start | Stop |
|---|
| Ventureselskaber og kapitalfonde (643040) | 11.03.2019 | |
| Investeringsselskaber (643030) | 01.01.2011 | 10.03.2019 |
| Uoplyst (999999) | 01.01.2008 | 31.12.2010 |
| Uoplyst (980000) | 08.05.2007 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 08.05.2007 (6404
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | SUNSTONE LIFE SCIENCE VENTURES FUND II K/S. |
| Sidst opdateret den 12.03.2015 og
angivet som gældende fra 08.05.2007 (6404
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af komplementaren. |
| Sidst opdateret den 02.03.2018 og
angivet som gældende fra 02.03.2018 (2453
dage). |
| Fortolkning
(1 tegningsmulighed)
| | komplementaren |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af komplementaren | 02.03.2018 | |
| Selskabet tegnes af komplementaren. Komplementarens tegningsregel skal kræve underskrift af mindst to medlemmer af komplementarens bestyrelse | 12.09.2008 | 01.03.2018 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:Deloitte Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33963556
Beskrivelse af revisor:State-Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional re-quirements applicable in Denmark. Our responsibilities under those standards and requirements are further de-scribed in the Auditor’s responsibilities for the audit of the financial statements section of this auditor’s report. We are independent of the Fund in accordance with the International Ethics Standards Board of Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion We have audited the financial statements of Sunstone Life Science Ventures Fund II K/S (“the Fund”) for the financial year 01. 01. 2023 - 31. 12. 2023, which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in net asset value, the statement of cash flows, and notes, including a summary of significant accounting policies. The financial statements are prepared in accordance with IFRS Accounting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Fund’s financial position at 31. 12. 2023 and of the results of its operations and cash flows for the financial year 01. 01. 2023 - 31. 12. 2023 in accordance with IFRS Accounting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management commentary Management is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the management commen-tary and, in doing so, consider whether the management commentary is materially inconsistent with the finan-cial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the management commentary is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration